Berapa harga Metagenomi, Inc. Common Stock (MGX)

Harga Metagenomi, Inc. Common Stock (MGX) adalah $1.21

Apa kapitalisasi pasar Metagenomi, Inc. Common Stock (MGX)

Kapitalisasi pasar Metagenomi, Inc. Common Stock (MGX) adalah $45.55M

Pendapatan Metagenomi, Inc. Common Stock (MGX)

Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developing therapeutic solutions for patients. The company utilizes a distinctive genome editing toolkit, sourced from metagenomics, for its development efforts within the United States. This advanced toolkit comprises programmable nucleases, base editors, and sophisticated RNA and DNA-mediated integration systems, notably prime editing and CRISPR-associated transposases. Metagenomi has established several key collaborations: a strategic alliance with ModernaTX, Inc. to explore new genome editing systems for in vivo human therapeutic applications; a development and licensing agreement with Affini-T Therapeutics, Inc. to create and commercialize gene-edited T-cell receptor therapies for human cancer; and a partnership with Ionis Pharmaceuticals, Inc. to research, develop, and market investigational medicines leveraging genome editing technologies. Founded in 2016, the company is based in Emeryville, California.

Tahun	Laba	Mengubah
Tidak cukup data untuk tanggal yang disediakan.

Tahun

Laba

Mengubah

Tidak cukup data untuk tanggal yang disediakan.

Perusahaan	Laba	Perbedaan Laba	Negara
Vertex Pharmaceuticals Incorporated VRTX.US	$5.27B	-	US
Argenx SE ARGX.US	$1.95B	-	NL
CSL Limited CSL.AX	$1.61B	-	AU
Lonza Group AG LONN.SW	-	-	CH
Moderna, Inc. MRNA.US	$-3.09B	-	US

Perusahaan

Laba

Perbedaan Laba

Negara